ACTSI Investigator Dr. Xiaodong Cheng in the News

Xiaodong Cheng, PhD, ACTSI investigator, biochemistry professor and Georgia Research Alliance Eminent Scholar, Emory University School of Medicine

Cell Therapy for Diabetes Neurovascular Complications: NIH $6.1M Grant Funds New Studies
October 4, 2011

Woodruff Health Sciences Update | Exploring cell therapy for diabetes complications
December 5, 2011

Dr. Cheng was selected as a 2012 Fellow of the American Association for the Advancement of Science (AAAS), an honor AAAS members bestow upon their peers. AAAS is the world's largest general scientific society and publisher of the journal Science. Cheng is a professor of biochemistry and a Georgia Research Alliance Eminent Scholar. He was cited by the AAAS for distinguished contributions to epigenetics by elucidating structural insights and enzymatic mechanisms of DNA and histonemodification enzymes.  

Upcoming Events

    View All Events

    Latest News


    ACTSI-supported OculoStaple Wins Again

    Atlanta Clinical & Translational Science Institute (ACTSI)-supported team, OculoStaple wins second place in the 2015 InVenture Prize at Georgia Tech. Team members Jackie Borinski, Mohamad Ali Najia, and Drew Padilla, all biomedical...


    Infographic: What are the Phases of Clinical Trials?